152 related articles for article (PubMed ID: 35150363)
1. Pseudo-T2 mapping for normalization of T2-weighted prostate MRI.
Sørland KI; Sunoqrot MRS; Sandsmark E; Langørgen S; Bertilsson H; Trimble CG; Lin G; Selnæs KM; Goa PE; Bathen TF; Elschot M
MAGMA; 2022 Aug; 35(4):573-585. PubMed ID: 35150363
[TBL] [Abstract][Full Text] [Related]
2. Automated reference tissue normalization of T2-weighted MR images of the prostate using object recognition.
Sunoqrot MRS; Nketiah GA; Selnæs KM; Bathen TF; Elschot M
MAGMA; 2021 Apr; 34(2):309-321. PubMed ID: 32737628
[TBL] [Abstract][Full Text] [Related]
3. Uncovering prostate cancer aggressiveness signal in T2-weighted MRI through a three-reference tissues normalization technique.
Algohary A; Zacharaki EI; Breto AL; Alhusseini M; Wallaengen V; Xu IR; Gaston SM; Punnen S; Castillo P; Pattany PM; Kryvenko ON; Spieler B; Abramowitz MC; Pra AD; Ford JC; Pollack A; Stoyanova R
NMR Biomed; 2024 Mar; 37(3):e5069. PubMed ID: 37990759
[TBL] [Abstract][Full Text] [Related]
4. Minimization of errors in biexponential T2 measurements of the prostate.
Gilani N; Rosenkrantz AB; Malcolm P; Johnson G
J Magn Reson Imaging; 2015 Oct; 42(4):1072-7. PubMed ID: 25704897
[TBL] [Abstract][Full Text] [Related]
5. A dual model HU conversion from MRI intensity values within and outside of bone segment for MRI-based radiotherapy treatment planning of prostate cancer.
Korhonen J; Kapanen M; Keyriläinen J; Seppälä T; Tenhunen M
Med Phys; 2014 Jan; 41(1):011704. PubMed ID: 24387496
[TBL] [Abstract][Full Text] [Related]
6. Combined morphological, [1H]-MR spectroscopic and contrast-enhanced imaging of human prostate cancer with a 3-Tesla scanner: preliminary experience.
Carlani M; Mancino S; Bonanno E; Finazzi Agrò E; Simonetti G
Radiol Med; 2008 Aug; 113(5):670-88. PubMed ID: 18493829
[TBL] [Abstract][Full Text] [Related]
7. Central gland and peripheral zone prostate tumors have significantly different quantitative imaging signatures on 3 Tesla endorectal, in vivo T2-weighted MR imagery.
Viswanath SE; Bloch NB; Chappelow JC; Toth R; Rofsky NM; Genega EM; Lenkinski RE; Madabhushi A
J Magn Reson Imaging; 2012 Jul; 36(1):213-24. PubMed ID: 22337003
[TBL] [Abstract][Full Text] [Related]
8. Relationship between T2 relaxation and apparent diffusion coefficient in malignant and non-malignant prostate regions and the effect of peripheral zone fractional volume.
Simpkin CJ; Morgan VA; Giles SL; Riches SF; Parker C; deSouza NM
Br J Radiol; 2013 Apr; 86(1024):20120469. PubMed ID: 23426849
[TBL] [Abstract][Full Text] [Related]
9. T2 Mapping in Prostate Cancer.
Mai J; Abubrig M; Lehmann T; Hilbert T; Weiland E; Grimm MO; Teichgräber U; Franiel T
Invest Radiol; 2019 Mar; 54(3):146-152. PubMed ID: 30394962
[TBL] [Abstract][Full Text] [Related]
10. Rapid quantitative T
Dregely I; Margolis DA; Sung K; Zhou Z; Rangwala N; Raman SS; Wu HH
Magn Reson Med; 2016 Dec; 76(6):1720-1729. PubMed ID: 26765746
[TBL] [Abstract][Full Text] [Related]
11. Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi-institutional study.
Ginsburg SB; Algohary A; Pahwa S; Gulani V; Ponsky L; Aronen HJ; Boström PJ; Böhm M; Haynes AM; Brenner P; Delprado W; Thompson J; Pulbrock M; Taimen P; Villani R; Stricker P; Rastinehad AR; Jambor I; Madabhushi A
J Magn Reson Imaging; 2017 Jul; 46(1):184-193. PubMed ID: 27990722
[TBL] [Abstract][Full Text] [Related]
12. T2* mapping combined with conventional T2-weighted image for prostate cancer detection at 3.0T MRI: a multi-observer study.
Wu LM; Yao QY; Zhu J; Lu Q; Suo ST; Liu Q; Xu JR; Chen XX; Haacke EM; Hu J
Acta Radiol; 2017 Jan; 58(1):114-120. PubMed ID: 26917785
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the size criterion for PI-RADSv2 category 5 upgrade: is 15 mm the best threshold?
An JY; Harmon SA; Mehralivand S; Czarniecki M; Smith CP; Peretti JA; Wood BJ; Pinto PA; Choyke PL; Shih JH; Turkbey B
Abdom Radiol (NY); 2018 Dec; 43(12):3436-3444. PubMed ID: 29752491
[TBL] [Abstract][Full Text] [Related]
14. Fully automated detection of prostate transition zone tumors on T2-weighted and apparent diffusion coefficient (ADC) map MR images using U-Net ensemble.
Wong T; Schieda N; Sathiadoss P; Haroon M; Abreu-Gomez J; Ukwatta E
Med Phys; 2021 Nov; 48(11):6889-6900. PubMed ID: 34418108
[TBL] [Abstract][Full Text] [Related]
15. Utility of Quantitative T2-Mapping Compared to Conventional and Advanced Diffusion Weighted Imaging Techniques for Multiparametric Prostate MRI in Men with Hip Prosthesis.
Sathiadoss P; Schieda N; Haroon M; Osman H; Alrasheed S; Flood TA; Melkus G
J Magn Reson Imaging; 2022 Jan; 55(1):265-274. PubMed ID: 34223675
[TBL] [Abstract][Full Text] [Related]
16. Deep learning-accelerated T2-weighted imaging of the prostate: Reduction of acquisition time and improvement of image quality.
Gassenmaier S; Afat S; Nickel D; Mostapha M; Herrmann J; Othman AE
Eur J Radiol; 2021 Apr; 137():109600. PubMed ID: 33610853
[TBL] [Abstract][Full Text] [Related]
17. Utility of T
Nketiah GA; Elschot M; Scheenen TW; Maas MC; Bathen TF; Selnæs KM;
Sci Rep; 2021 Jan; 11(1):2085. PubMed ID: 33483545
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Weighted Diffusion Subtraction for Detection of Clinically Significant Prostate Cancer.
Sato T; Isoda H; Fujimoto K; Furuta A; Fujimoto M; Ito K; Kobayashi T; Nakamoto Y
J Magn Reson Imaging; 2021 Dec; 54(6):1979-1988. PubMed ID: 34085328
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer: Comparison of 3D T2-weighted with conventional 2D T2-weighted imaging for image quality and tumor detection.
Rosenkrantz AB; Neil J; Kong X; Melamed J; Babb JS; Taneja SS; Taouli B
AJR Am J Roentgenol; 2010 Feb; 194(2):446-52. PubMed ID: 20093608
[TBL] [Abstract][Full Text] [Related]
20. A Single-Arm, Multicenter Validation Study of Prostate Cancer Localization and Aggressiveness With a Quantitative Multiparametric Magnetic Resonance Imaging Approach.
Maas MC; Litjens GJS; Wright AJ; Attenberger UI; Haider MA; Helbich TH; Kiefer B; Macura KJ; Margolis DJA; Padhani AR; Selnæs KM; Villeirs GM; Fütterer JJ; Scheenen TWJ
Invest Radiol; 2019 Jul; 54(7):437-447. PubMed ID: 30946180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
